Arxspan BioDrive: A Versatile Solution for Molecular Biology

In this interview, NewsMedical speaks to Arxspan about its new all-in-one solution for molecular biology.

Diabetes in Night Owls; ‘Paradigm-Shifting’ Drugs; Transgender Trials Unethical?

Compared with women who are early birds, night owls had a 19% higher risk of developing diabetes, after taking into account lifestyle and sociodemographic factors.

September 20, 2023

Q3 2023 Digital Health Funding Stalls at $2.5B

What You Should Know: The digital health sector has encountered substantial declines in funding and deal volume; however, quarterly trends are now stabilizing within a

October 3, 2023

Silence Therapeutics Plc Patent: Compound for RNA Interference Therapy in Liver Disease

According to GlobalData’s company profile on Silence Therapeutics, was a key innovation area identified from patents. Silence Therapeutics‘s grant share as of April 2024 was

June 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.